Strategies for following dry age-related macular degeneration

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Spectral domain optical coherence tomography (SDOCT) provides a novel strategy for imaging and monitoring progression in patients with age-related macular degeneration (AMD). The advantage of SDOCT over other imaging modalities or functional tests is that one modality can be used to image both drusen and geographic atrophy while obtaining reproducible, quantitative data on both drusen morphology and the area of geographic atrophy. Moreover, this strategy enables the clinician to follow the disease as it progresses from drusen to both geographic atrophy and choroidal neovascularization. No other imaging modality is able to quantitatively assess all forms of AMD. This unique feature of SDOCT makes it the ideal imaging modality for monitoring patients with AMD, providing routine care, and for following patients in clinical trials designed to assess the efficacy of new drugs for the treatment of dry AMD.

Original languageEnglish
Pages (from-to)6-10
Number of pages5
JournalOphthalmic Research
Volume48
Issue numberSUPPL. 1
DOIs
StatePublished - Aug 1 2012

Fingerprint

Geographic Atrophy
Macular Degeneration
Optical Coherence Tomography
Choroidal Neovascularization
Physiologic Monitoring
Patient Care
Clinical Trials
Pharmaceutical Preparations
Therapeutics

Keywords

  • Choroidal neovascularization
  • Drusen
  • Geographic atrophy
  • Progression
  • Spectral domain optical coherence tomography

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Strategies for following dry age-related macular degeneration. / Yehoshua, Zohar; Rosenfeld, Philip J.

In: Ophthalmic Research, Vol. 48, No. SUPPL. 1, 01.08.2012, p. 6-10.

Research output: Contribution to journalArticle

@article{4bedb8d49f194972905f0efda249a058,
title = "Strategies for following dry age-related macular degeneration",
abstract = "Spectral domain optical coherence tomography (SDOCT) provides a novel strategy for imaging and monitoring progression in patients with age-related macular degeneration (AMD). The advantage of SDOCT over other imaging modalities or functional tests is that one modality can be used to image both drusen and geographic atrophy while obtaining reproducible, quantitative data on both drusen morphology and the area of geographic atrophy. Moreover, this strategy enables the clinician to follow the disease as it progresses from drusen to both geographic atrophy and choroidal neovascularization. No other imaging modality is able to quantitatively assess all forms of AMD. This unique feature of SDOCT makes it the ideal imaging modality for monitoring patients with AMD, providing routine care, and for following patients in clinical trials designed to assess the efficacy of new drugs for the treatment of dry AMD.",
keywords = "Choroidal neovascularization, Drusen, Geographic atrophy, Progression, Spectral domain optical coherence tomography",
author = "Zohar Yehoshua and Rosenfeld, {Philip J}",
year = "2012",
month = "8",
day = "1",
doi = "10.1159/000339841",
language = "English",
volume = "48",
pages = "6--10",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Strategies for following dry age-related macular degeneration

AU - Yehoshua, Zohar

AU - Rosenfeld, Philip J

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Spectral domain optical coherence tomography (SDOCT) provides a novel strategy for imaging and monitoring progression in patients with age-related macular degeneration (AMD). The advantage of SDOCT over other imaging modalities or functional tests is that one modality can be used to image both drusen and geographic atrophy while obtaining reproducible, quantitative data on both drusen morphology and the area of geographic atrophy. Moreover, this strategy enables the clinician to follow the disease as it progresses from drusen to both geographic atrophy and choroidal neovascularization. No other imaging modality is able to quantitatively assess all forms of AMD. This unique feature of SDOCT makes it the ideal imaging modality for monitoring patients with AMD, providing routine care, and for following patients in clinical trials designed to assess the efficacy of new drugs for the treatment of dry AMD.

AB - Spectral domain optical coherence tomography (SDOCT) provides a novel strategy for imaging and monitoring progression in patients with age-related macular degeneration (AMD). The advantage of SDOCT over other imaging modalities or functional tests is that one modality can be used to image both drusen and geographic atrophy while obtaining reproducible, quantitative data on both drusen morphology and the area of geographic atrophy. Moreover, this strategy enables the clinician to follow the disease as it progresses from drusen to both geographic atrophy and choroidal neovascularization. No other imaging modality is able to quantitatively assess all forms of AMD. This unique feature of SDOCT makes it the ideal imaging modality for monitoring patients with AMD, providing routine care, and for following patients in clinical trials designed to assess the efficacy of new drugs for the treatment of dry AMD.

KW - Choroidal neovascularization

KW - Drusen

KW - Geographic atrophy

KW - Progression

KW - Spectral domain optical coherence tomography

UR - http://www.scopus.com/inward/record.url?scp=84865391110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865391110&partnerID=8YFLogxK

U2 - 10.1159/000339841

DO - 10.1159/000339841

M3 - Article

C2 - 22907143

AN - SCOPUS:84865391110

VL - 48

SP - 6

EP - 10

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

IS - SUPPL. 1

ER -